Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C21H23F3O5S
CAS Number:
Molecular Weight:
444.46
MDL number:
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
(liquid, semi-solid, solid or powder)
Quality Segment
assay
≥98% (HPLC)
form
(liquid, semi-solid, solid or powder)
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
OC(COC1=C(C=C(C=C1)SC[C@H](OCC)COC2=CC=C(C=C2)C(F)(F)F)C)=O
Application
Biochem/physiol Actions
Seladelpar (MBX-8025) is an orally active, potent and selective Peroxisome proliferator–activated receptor delta (PPAR-δ) agonist (EC50 = 2 nM post 24h treatment using HEK293 PPARβ/δ reporter cells) with >750- and >2500-fold higher potency over that of PPAR-α and PPAR-γ, respectively. Seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice in vivo (10 mg/kg/d via liquid diet). Seladelpar plays a significant role in regulating bile acid metabolism and inflammation. By activating PPARδ, seladelpar promotes fatty acid oxidation and reduces lipid accumulation in the liver, which is predominantly observed in primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH). PPARδ activation also results in the downregulation of bile acid synthesis by reducing the expression of cholesterol 7 alpha-hydroxylase (CYP7A1), a key enzyme in bile acid synthesis. Seladelpar also enhances the signaling of fibroblast growth factor 21 (FGF21), contributing to its anti-inflammatory effects.
Storage Class
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.